MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 7, 2008; DOI: 10.1124/mol.108.051276


0026-895X/09/7502-381-396$20.00
Mol Pharmacol 75:381-396, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.108.051276v1
75/2/381    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tran, J. A.
Right arrow Articles by Ehlert, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tran, J. A.
Right arrow Articles by Ehlert, F. J.

Estimation of Relative Microscopic Affinity Constants of Agonists for the Active State of the Receptor in Functional Studies on M2 and M3 Muscarinic ReceptorsFormula

John A. Tran, Alexander Chang, Minoru Matsui, and Frederick J. Ehlert

Department of Pharmacology, College of Medicine, University of California, Irvine, California (J.A.T., A.C., F.J.E.); and Department of Pharmacy, Chiba Institute of Science, Chiba, Japan (M.M.)

In prior work, we have shown that it is possible to estimate the product of observed affinity and intrinsic efficacy of an agonist expressed relative to that of a standard agonist simply through the analysis of their respective concentration-response curves. In this report, we show analytically and through mathematical modeling that this product, termed intrinsic relative activity (RAi), is equivalent to the ratio of microscopic affinity constants of the agonists for the active state of the receptor. We also compared the RAi estimates of selected muscarinic agonists with a relative estimate of the product of observed affinity and intrinsic efficacy determined independently through the method of partial receptor inactivation. There was good agreement between these two estimates when agonist-mediated inhibition of forskolin-stimulated cAMP accumulation was measured in Chinese hamster ovary cells stably expressing the human M2 muscarinic receptor. Likewise, there was good agreement between the two estimates when agonist activity was measured on the ileum from M2 muscarinic receptor knockout mice, a convenient assay for M3 receptor activity. The RAi estimates of agonists in the mouse ileum were similar to those estimated at the human M3 receptor with the exception of 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343), which is known to be an M1- and M4-selective muscarinic agonist. Additional experiments showed that the response to McN-A-343 in the mouse ileum included a non-M3 muscarinic receptor component. Our results show that the RAi estimate is a useful receptor-dependent measure of agonist activity and ligand-directed signaling.


Received for publication August 11, 2008.

Accepted for publication November 6, 2008.

Address correspondence to: Dr. Frederick J. Ehlert, Department of Pharmacology, University of California, Irvine, Irvine, California 92698-4625. E-mail: fjehlert{at}uci.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics